Inventor

TSOU CHIH-CHIANG

US74 patents

Patents

50 patents

US10772915B2Sep 15, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations93

US10709738B2Jul 14, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations93

US10695374B2Jun 30, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations93

US11020433B2Jun 1, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH2 citations84

US11951132B2Apr 9, 2024

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11918607B2Mar 5, 2024

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11801264B2Oct 31, 2023

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11779606B2Oct 10, 2023

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11376281B2Jul 5, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11369636B2Jun 28, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11357797B2Jun 14, 2022

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11197892B2Dec 14, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11179418B2Nov 23, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11154576B2Oct 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11147839B2Oct 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11147838B2Oct 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11141437B2Oct 12, 2021

Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11103535B2Aug 31, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11077142B2Aug 3, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11065279B2Jul 20, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11058727B2Jul 13, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11052114B2Jul 6, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11052113B2Jul 6, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11040069B2Jun 22, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11033583B2Jun 15, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11033585B2Jun 15, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11026977B2Jun 8, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11020434B2Jun 1, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013768B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013769B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US11013766B2May 25, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10993962B2May 4, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10993964B2May 4, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10905720B2Feb 2, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10905719B2Feb 2, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10898518B2Jan 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10898519B2Jan 26, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10894064B2Jan 19, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888585B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888584B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888582B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888586B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10888583B2Jan 12, 2021

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73

US10874695B2Dec 29, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10874696B2Dec 29, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10869894B2Dec 22, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10869890B2Dec 22, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10869893B2Dec 22, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10869891B2Dec 22, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

US10869896B2Dec 22, 2020

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations63

Showing the top 50 of 74 patents by PatentIndex Score.